MCM7 and prostate carcinoma: Furthermore, some of the targets predicted by TaLasso for miR-1 were related to the cancers in MCC data: for instance, MCM7, related to prostate cancer progression [35] and TAGLN2, a colorectal cancer biomarker [35].